D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 11.63% |
| 3 | Healthcare | 11.01% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
IMAX
IMAX
$2.59B
| $880K | ﹤0.01% |
46,776
-183,018
| -80% | -$3.73M |
|
2702
CALL
Wyndham Hotels & Resorts
WH
$5.62B
| $880K | ﹤0.01% |
19,400
| – | – |
|
2703
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $878K | ﹤0.01% |
35,261
-59,575
| -63% | -$1.51M |
|
|
AKS
2704
DELISTED
AK Steel Holding Corp
AKS
| $878K | ﹤0.01% |
390,206
-932,274
| -70% | -$3.37M |
|
2705
Compañía de Cervecerías Unidas
CCU
$2.2B
| $874K | ﹤0.01% |
34,759
+20,359
| +141% | +$527K |
|
2706
Kinsale Capital Group
KNSL
$8.43B
| $873K | ﹤0.01% |
+15,719
| New | +$929K |
|
2707
PUT
Ternium
TX
$9.68B
| $873K | ﹤0.01% |
32,200
+10,700
| +50% | +$319K |
|
|
REN
2708
PUT
DELISTED
Resolute Energy Corporaton
REN
| $869K | ﹤0.01% |
+30,000
| New | +$947K |
|
2709
Penske Automotive Group
PAG
$14.5B
| $868K | ﹤0.01% |
21,522
-4,102
| -16% | -$177K |
|
2710
Williams-Sonoma
WSM
$27.8B
| $868K | ﹤0.01% |
34,396
-847,476
| -96% | -$24.2M |
|
2711
PUT
NN Inc
NNBR
$261M
| $866K | ﹤0.01% |
129,000
+50,000
| +63% | +$480K |
|
|
ITCI
2712
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $866K | ﹤0.01% |
76,000
| – | – |
|
2713
CALL
Royal Gold
RGLD
$16.6B
| $865K | ﹤0.01% |
10,100
-2,700
| -21% | -$208K |
|
2714
Choice Hotels
CHH
$5.22B
| $858K | ﹤0.01% |
11,990
-7,475
| -38% | -$561K |
|
2715
PUT
CRISPR Therapeutics
CRSP
$4.68B
| $857K | ﹤0.01% |
+30,000
| New | +$1.04M |
|
2716
PUT
PG&E
PCG
$39.2B
| $857K | ﹤0.01% |
36,100
-113,900
| -76% | -$4.08M |
|
2717
CALL
TTEC Holdings
TTEC
$119M
| $857K | ﹤0.01% |
30,000
| – | – |
|
2718
Altisource Portfolio Solutions
ASPS
$58.1M
| $856K | ﹤0.01% |
4,759
-5,234
| -52% | -$1.05M |
|
|
IMMU
2719
PUT
DELISTED
Immunomedics Inc
IMMU
| $856K | ﹤0.01% |
60,000
| – | – |
|
|
K
2720
CALL
DELISTED
Kellanova
K
| $855K | ﹤0.01% |
15,975
| – | – |
|
2721
uniQure
QURE
$2.52B
| $855K | ﹤0.01% |
29,657
-38,496
| -56% | -$1.07M |
|
2722
PUT
PTC
PTC
$14.7B
| $854K | ﹤0.01% |
10,300
| – | – |
|
|
ARQL
2723
DELISTED
Arqule Inc
ARQL
| $854K | ﹤0.01% |
308,056
+134,778
| +78% | +$514K |
|
|
CRZO
2724
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $854K | ﹤0.01% |
75,600
-49,500
| -40% | -$881K |
|
2725
PUT
BlackBerry
BB
$4.74B
| $853K | ﹤0.01% |
120,000
-2,000
| -2% | -$17.6K |
|
Similar funds
D.E. Shaw & Co's Q4 2018 Portfolio in Review
As of Q4 2018, D.E. Shaw & Co held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
D.E. Shaw & Co deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- D.E. Shaw & Co's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- D.E. Shaw & Co added most to Oracle in Q4 2018, an estimated $431M increase.
- D.E. Shaw & Co's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- D.E. Shaw & Co fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- D.E. Shaw & Co's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- D.E. Shaw & Co opened 541 new positions and closed 497 in Q4 2018.
- D.E. Shaw & Co's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.